arimixyl kalpa pharmaceuticals
Arimixyl by Kalpa Pharmaceuticals
Arimixyl is an oral aromatase inhibitor manufactured by the Kalpa Pharmaceuticals and approved for use in the United States in 1995s.

Oftentimes, Anastrozole is often compared to Nolvadex as these two products both help reduction of estrogenic activity in the body. Arimixyl is more effective in combating estrogen-related concerns.

For bodybuilders, Anastrozole is very effective in reducing excess estrogen. It is usually taken with Nolvadex to avoid estrogen-related side effects. If used with Finasteride, the outcome is much better.

If used with Testosterone, Arimixyl gives impressive muscle gains with small water retention and gynecomastia. The result is a ripped and defined muscle.

Anastrozole use (as mentioned below) is the likely occurrence of fractures, a major drawback of this drug. This is because when Anastrozole effectively blocks the formation of estrogen, it effectively blocks the benefits of this hormone as well. This is why many still decide for estrogen receptor antagonists like Nolvadex and Clomid because these drugs allow some estrogen activity in the body.

Arimixyl side effects involve weakness, confusion, problems with vision, speech, or balance;

Arimixyl dosage for males is from 0.5mg to 3mg. Because Anastrozole has a short active life, dosages are usually taken two to six times a day at equal intervals. In clinical studies, it has been observed that a daily dose of 1 mg of this drug results to more than 80% of estrogen suppression.
One of the principal drawbacks of Arimixyl is its high cost. Recreational bodybuilders would not opt for this drug despite its effectiveness for the simple fact that it is too expensive. For atheletes into competitive bodybuilding, price is not the primary concern and they generally choose Anastrozole as it delivers qualitative gains.